Literature DB >> 2612538

Human scalp hair as evidence of individual dosage history of haloperidol: method and retrospective study.

T Uematsu1, R Sato, K Suzuki, S Yamaguchi, M Nakashima.   

Abstract

Hair samples and morning pre-dose plasma were collected from 40 patients who had received fixed daily doses of haloperidol for more than four months and whose compliance was good. After washing, 1 to 2 cm-long portions nearest to the roots of 2 to 3 strands of hair were completely dissolved in 2.5N NaOH. Haloperidol in that sample or alkalinised plasma was extracted and measured by RIA. Haloperidol concentrations in hair correlated well both with the trough concentration in plasma at steady-state (r = 0.772, n = 39) and with the daily dose (r = 0.555, n = 40). Another keratinized tissue, nail, was also collected from 20 of the 40 patients and the haloperidol level was compared with that in hair. The former was only about 4.3% of the latter and was significantly correlated only with the daily dose (r = 0.525, n = 20). Hair from 10 other patients in whom the dosage of haloperidol had been changed within a few months prior to sampling the hair was cut into 0.5 or 1 cm-long portions from the roots and the drug concentration in each portion was measured. If hairs were assumed to grow at 1 cm/month, a history of individual dosage could be deduced in 9 of the 10 patients from the distribution of drug level along the length of the hair. The results suggest that human scalp hair could serve as a useful tool for monitoring individual dosage history over several months, or in demonstrating exposure or non-exposure of a patient to a drug.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2612538     DOI: 10.1007/bf00679777

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  Pathologic dynamics of human hair loss. I. Telogen effuvium.

Authors:  A M KLIGMAN
Journal:  Arch Dermatol       Date:  1961-02

2.  Chronic plumbism in children. Diagnosis by hair analysis.

Authors:  L Kopito; A M Briley; H Shwachman
Journal:  JAMA       Date:  1969-07-14       Impact factor: 56.272

3.  Trace metals in human hair.

Authors:  H A Schroeder; A P Nason
Journal:  J Invest Dermatol       Date:  1969-07       Impact factor: 8.551

4.  Pharmacokinetic studies on haloperidol in man.

Authors:  A Forsman; R Ohman
Journal:  Curr Ther Res Clin Exp       Date:  1976-09

5.  Serum and CSF levels of haloperidol by radioimmunoassay and radioreceptor assay during high-dose therapy of resistant schizophrenic patients.

Authors:  R Rimón; I Averbuch; P Rozick; L Fijman-Danilovich; T Kara; H Dasberg; R P Ebstein; R H Belmaker
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

6.  Studies on serum protein binding of haloperidol.

Authors:  A Forsman; R Ohman
Journal:  Curr Ther Res Clin Exp       Date:  1977-02

Review 7.  Plasma level monitoring of antipsychotic drugs. Clinical utility.

Authors:  S G Dahl
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

8.  Detection of phencyclidine in hair.

Authors:  A M Baumgartner; P F Jones; C T Black
Journal:  J Forensic Sci       Date:  1981-07       Impact factor: 1.832

9.  Trace elements in scalp-hair of persons with multiple sclerosis and of normal individuals.

Authors:  D E Ryan; J Holzbecher; D C Stuart
Journal:  Clin Chem       Date:  1978-11       Impact factor: 8.327

10.  Determination of haloperidol in human serum by radioimmunoassay.

Authors:  H Suzuki; Y Minaki; M Iwaisaki; Y Sekine; A Kagemoto; Y Utsui; M Hashimoto; G Yagi; H Itoh
Journal:  J Pharmacobiodyn       Date:  1980-05
View more
  9 in total

Review 1.  Drugs in nails: physiology, pharmacokinetics and forensic toxicology.

Authors:  A Palmeri; S Pichini; R Pacifici; P Zuccaro; A Lopez
Journal:  Clin Pharmacokinet       Date:  2000-02       Impact factor: 6.447

2.  Comparative dispositions of ofloxacin in human head, axillary, and pubic hairs.

Authors:  K Kosuge; T Uematsu; S I Araki; H Matsuno; K Ohashi; M Nakashima
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 3.  Therapeutic drug monitoring in hair samples. Principles and practice.

Authors:  T Uematsu
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

4.  Human scalp hair as evidence of individual dosage history of haloperidol: a possible linkage of haloperidol excretion into hair with hair pigment.

Authors:  T Uematsu; R Sato; O Fujimori; M Nakashima
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

5.  The measurement of ofloxacin in hair as an index of exposure.

Authors:  T Uematsu; N Miyazawa; M Nakashima
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  Chlorpromazine in human scalp hair as an index of dosage history: comparison with simultaneously measured haloperidol.

Authors:  H Sato; T Uematsu; K Yamada; M Nakashima
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Using ofloxacin as a time marker in hair analysis for monitoring the dosage history of haloperidol.

Authors:  M Nakano; T Uematsu; H Sato; K Kosuge; M Nishimoto; M Nakashima
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

8.  The measurement of a new antimicrobial quinolone in hair as an index of drug exposure.

Authors:  T Uematsu; M Nakano; H Akiyama; M Nakashima
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

9.  Analysis of a new fluoroquinolone derivative (Q-35) in human scalp hair as an index of drug exposure and as a time marker in hair.

Authors:  T Uematsu; Y Ohsawa; A Mizuno; M Nakashima
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.